Gene · 7439
BEST1: bestrophin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BEST1: bestrophin 1. Genes, record 7439. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7439
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O76090 | Bestrophin-1 | 585 | 19 | Ensembl, GeneID, HGNC |
Source UniProt
Patents40
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026515744 A | 2026-05-19 | 195 | O76090 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38939 | O76090 | Espacenet |
| EP 4667578 A2 | 2025-12-24 | 178 | O76090 | Espacenet |
| JP 2025131621 A | 2025-09-09 | 178 | O76090 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 577 | O76090 | Espacenet |
| EP 4590841 A2 | 2025-07-30 | 14 | O76090 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 577 | O76090 | Espacenet |
| JP 2025514710 A | 2025-05-09 | 178 | O76090 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8936 | O76090 | Espacenet |
| US 12246072 B2 | 2025-03-11 | 12 | O76090 | Espacenet |
1 to 10 of 40
See all 40 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants844
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BEST1 papers | Newest fiscal year |
|---|---|---|---|
| R01EY018213 | Defining Barriers to Gene Therapy | 15 | 2025 |
| P30EY001583 | P30 Core Grant For Vision Research | 11 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 10 | 2025 |
| P30EY000331 | Vision Research Core at UCLA | 10 | 2025 |
| R01EY006855 | Models for Therapy of Hereditary Retinal Degeneration | 10 | 2025 |
| R01EY024698 | Gene Editing and Silencing in Phototransduction | 10 | 2025 |
| P30EY005722 | Center Core Grant for Vision Research | 6 | 2025 |
| P30EY006360 | P30-Core Grant for Vision Research | 6 | 2025 |
| P30EY022589 | NEI Center Core Grant for Vision Research | 6 | 2025 |
| P30EY025580 | Multidisciplinary Investigations in Visual Science | 6 | 2025 |
1 to 10 of 844Source NIH's project files
See all 844 nih grantsPapers1,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Astrocytes Coordinate Neurovascular Coupling During Prolonged Sensory Demand via AQP4/TRPA1/BEST1/D-Serine Signaling. | Adv Sci (Weinh) | 2026 | 42811508 | PubTator, text mining | PubMed |
| Expanding the genotype-phenotype spectrum of autosomal recessive bestrophinopathy: a clinicogenetic report of Filipino siblings with compound heterozygous BEST1 variants. | Eye (Lond) | 2026 | 42811081 | PubTator, text mining | PubMed |
| Case Report: Acute angle-closure glaucoma as the initial presentation of autosomal recessive bestrophinopathy caused by compound heterozygous BEST1 mutations. | Front Med (Lausanne) | 2026 | 42774095 | PubTator, text mining | PubMed |
| Characterization of Ocular Developmental Disorders in the Israeli Population: Genotype-Phenotype Correlations and Novel Candidate Genes. | Biomolecules | 2026 | 42650885 | PubTator, text mining | PubMed |
| Dissecting Missing Heritability in Rare Inherited Macular Dystrophies. | Genes (Basel) | 2026 | 42650171 | PubTator, text mining | PubMed |
| Dual-restricted AAV gene delivery via suprachoroidal administration mediates precision RPE SOCS3 restoration for dry age-related macular degeneration. | J Control Release | 2026 | 42636893 | PubTator, text mining | PubMed |
| CircMETTL3 Inhibits H2O2-Induced Senescence, Oxidative Stress, and DNA Damage in ARPE-19 Cells via miR-100/BMPR2 Axis. | J Ophthalmol | 2026 | 42626541 | PubTator, text mining | PubMed |
| AAV-NRF2 protects retinal and choroidal vasculature in a GDF15-dependent manner in an oxidative damage model of AMD. | Proc Natl Acad Sci U S A | 2026 | 42579492 | PubTator, text mining | PubMed |
| Bestrophinopathies: Clinical Characteristics, Natural History, and Genetic Landscape. | Ophthalmol Retina | 2026 | 42559932 | PubTator, text mining | PubMed |
| Ocular Safety and Efficacy of AAV-mediated Tyrosinase Gene Augmentation in a Nonhuman Primate Model. | bioRxiv | 2026 | 42523373 | PubTator, text mining | PubMed |
1 to 10 of 1,518
See all 1,518 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7439
GET https://conductscience.org/api/genes/v1/7439/patents?page=2